Bioventus (BVS) EBT Margin Growth (1y) (2021 - 2026)
Bioventus (BVS) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | -719.00 |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 687.00 |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 88.00 |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 374.00 |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 343.00 |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 84.00 |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | -126.00 |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 165.00 |
| 10 | Bioventus | 975.28 Mn | 945.82 Mn | 105.67 Mn | 301.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 301.00 |
| Mar 28, 2026 | 618.00 |
| Dec 31, 2025 | 899.00 |
| Sep 27, 2025 | 715.00 |
| Jun 28, 2025 | 3,447.00 |
| Mar 29, 2025 | 147.00 |
| Dec 31, 2024 | 617.00 |
| Sep 28, 2024 | 300.00 |
| Jun 29, 2024 | -2,431.00 |
| Mar 30, 2024 | 7,990.00 |
| Dec 31, 2023 | 1,957.00 |
| Sep 30, 2023 | 9,469.00 |
| Jul 1, 2023 | 145.00 |
| Apr 1, 2023 | -6,747.00 |
| Dec 31, 2022 | -2,367.00 |
| Oct 1, 2022 | -9,858.00 |
| Jul 2, 2022 | 363.00 |
| Apr 2, 2022 | -4,656.00 |
| Dec 31, 2021 | -529.00 |
| Oct 2, 2021 | -1,260.00 |